pfizer building


The Latest

Does the proposed Midtown East rezoning incentivize Pfizer to skip town?

Does the proposed Midtown East rezoning incentivize Pfizer to skip town?

The density boost that the Pfizer headquarters will automatically get under the Midtown East rezoning means that the pharmaceutical...

Does the proposed Midtown East rezoning incentivize Pfizer to skip town?
Pfizer sells last piece of its Broadway Triangle site for $28M

Pfizer sells last piece of its Broadway Triangle site for $28M

Pfizer sold the last remaining piece of its development site at Brooklyn’s Broadway Triangle. Developer Abraham Brach paid $27.5...

Pfizer sells last piece of its Broadway Triangle site for $28M
Pfizer testing out brokers to sell Midtown East buildings

Pfizer testing out brokers to sell Midtown East buildings

Pharmaceutical giant Pfizer, which is gearing up to move to a new headquarters, is on the hunt to find...

Pfizer testing out brokers to sell Midtown East buildings
630 Flushing Avenue

FreshDirect leases 20K sf at old Pfizer site in Brooklyn

While FreshDirect is moving its headquarters to the South Bronx, the online grocer is also leasing some space in...

FreshDirect leases 20K sf at old Pfizer site in Brooklyn
Acumen aiming for double-digit returns at Pfizer building

Acumen aiming for double-digit returns at Pfizer building

After paying $26 million in 2011 for a shuttered Pfizer plant in Brooklyn, Acumen Capital Partners is shooting for...

Acumen aiming for double-digit returns at Pfizer building
Former Pfizer property

Brooklyn deputy beep pushes to keep Pfizer property industrial

Brooklyn’s newly appointed deputy borough president is pushing to have a Williamsburg industrial property declared part of an “Industrial...

Brooklyn deputy beep pushes to keep Pfizer property industrial
Placeholder image

Low bids for Pfizer building signal weak market: experts

685 Third Avenue The relatively low bidding offers coming in for the Pfizer building at 685 Third Avenue reflect...

Low bids for Pfizer building signal weak market: experts
Placeholder image

Low bids for Pfizer building signal weak market: experts

685 Third Avenue The relatively low bidding offers coming in for the Pfizer building at 685 Third Avenue reflect...

Low bids for Pfizer building signal weak market: experts
« Previous Next »

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...